Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Marine Biological Laboratory of Massachusetts

Latest From Marine Biological Laboratory of Massachusetts

Finance Watch: 3Q Biopharma Venture Capital Financings Fell From 2Q Spike

VC deals totaled $8.3bn in the first half of 2019, but the year's total rose to just $11.5bn at the end of September, reflecting only a $3.2bn third quarter gain. Among recent financings, Cygnal emerged from stealth mode with $65m invested to date.

Financing StartUps and SMEs

Chaperone Technologies Inc.

More than 70% of the bacteria that cause hospital-acquired infections are resistant to at least one of the broad-spectrum antibiotics most commonly used to treat them. By targeting peptides at a single vital intracellular structure found in all microbes, Chaperone Technologies hopes to solve the drug resistance problem for good.

See All

Company Information

  • Industry
  • Academic and Research Institutions